1,505
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials

, , , , , , , , , , & show all
Article: 2324833 | Received 11 Dec 2023, Accepted 23 Feb 2024, Published online: 12 May 2024